SCHEMBL25538403

SCHEMBL25538403

CC1(C)c2cc3ccccc3cc2-c2cccc(-c3ccc(-c4cc(-c5ccc6ccccc6c5)nc(-c5cccc6ccccc56)n4)c4ccccc34)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.45
CYP1A2 P05177 1/20 0.37
CTRC Q99895 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
RAC1 P63000 2/20 0.33
ENPP3 O14638 1/20 0.33
ENPP1 P22413 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MAOB P27338 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25539697 0.92 CYP1A1 (0.45) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25534330 0.92 PIM1 (0.46) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25534541 0.92 PIM1 (0.46) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25540325 0.92 CYP1A1 (0.45) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25540484 0.92 MEN1 (0.37) PIM1ENPP3ENPP1MEN1KMT2A
SCHEMBL25538402 0.92 MEN1 (0.37) PIM1ENPP3ENPP1MEN1KMT2A
SCHEMBL25538399 0.91 PIM1 (0.35) PIM1CYP1A1CYP1B1ENPP3ENPP1
SCHEMBL25538215 0.91 PIM1 (0.42) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25537176 0.91 CYP1A1 (0.41) PIM1CYP1A2CTRCCYP1A1CYP1B1
SCHEMBL25539690 0.91 MEN1 (0.36) PIM1CYP1A2ENPP3ENPP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM PIM1 1763/4885CYP1A2 1590/4885CTRC 3942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.